← FDA Drug Approvals (Drugs@FDA)

TRI-LO-MILI

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2016-11-04

Drug application

FDA Application #

ANDA205762

Application type

Abbreviated New Drug Application (Generic)

Brand name

TRI-LO-MILI

Generic name

NORGESTIMATE AND ETHINYL ESTRADIOL

Active ingredients

ETHINYL ESTRADIOL; NORGESTIMATE

Dosage form

TABLET

Route

ORAL-28

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2016-11-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown